Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02684838 · ClinicalTrials.gov registry record

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

A clinical trial, sponsored by Arbor Pharmaceuticals.

Completed
Registry status
272
Enrollment target

NCT02684838 is a clinical trial that has completed, run by Arbor Pharmaceuticals. The registered enrollment target is 272 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02684838 has completed, sponsored by Arbor Pharmaceuticals.

COMPLETED
Registry status
272 participants
Enrollment target

Study Summary

This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care.

Trial Details

FieldValue
Enrollment Target 272 participants
Start Date 2016-04-26
Est. Completion 2025-06-23

Sponsor

Arbor Pharmaceuticals

14 total trials

What the Registry Record Tells You About NCT02684838

The ClinicalTrials.gov registry entry for NCT02684838 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arbor Pharmaceuticals, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02684838 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02684838 about?

NCT02684838 is a clinical study titled "Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry". This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care.

What is the current status of trial NCT02684838?

This trial is currently completed. The enrollment target is 272 participants. The study started on 2016-04-26. Estimated completion is 2025-06-23.

Who is sponsoring clinical trial NCT02684838?

This trial is sponsored by Arbor Pharmaceuticals, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.